Literature DB >> 28049555

FOXP3-Positive Regulatory T Cells and Kidney Allograft Tolerance.

Alessandro Alessandrini1, Laurence A Turka2.   

Abstract

Normal immune homeostasis is achieved by several mechanisms, and prominent among them is immunoregulation. Although several types of regulatory lymphocyte populations have been described, CD4 T cells expressing the FOXP3 transcription factor (FOXP3-positive regulatory T cells [FOXP3+ Tregs]) are the best understood. This population of cells is critical for maintaining self-tolerance throughout the life of the organism. FOXP3+ Tregs can develop within the thymus, but also under select circumstances, naive peripheral T cells can be induced to express FOXP3 and become stable Tregs as well. Abundant evidence from animal systems, as well as limited evidence in humans, implicates Tregs in transplant tolerance, although whether these Tregs recognize allo- or self-antigens is not clear. New translational approaches to promote immunosuppression minimization and/or actual tolerance are being designed to exploit these observations. These include strategies to boost the generation, maintenance, and stability of endogenous Tregs, as well as adoptive cellular therapy with exogenous Tregs.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Foxp3(+) Tregs; Regulatory T cells; cellular therapy; end-stage renal disease (ESRD); immunoregulation; immunotherapy; kidney allografts; kidney transplant tolerance; renal transplantation; review; self-tolerance; transplant tolerance

Mesh:

Substances:

Year:  2016        PMID: 28049555      PMCID: PMC5403573          DOI: 10.1053/j.ajkd.2016.10.027

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  82 in total

1.  Messenger RNA for FOXP3 in the urine of renal-allograft recipients.

Authors:  Thangamani Muthukumar; Darshana Dadhania; Ruchuang Ding; Catherine Snopkowski; Rubina Naqvi; Jun B Lee; Choli Hartono; Baogui Li; Vijay K Sharma; Surya V Seshan; Sandip Kapur; Wayne W Hancock; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

2.  From vanilla to 28 flavors: multiple varieties of T regulatory cells.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

Review 3.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

4.  Transplantation of anergic histoincompatible bone marrow allografts.

Authors:  E C Guinan; V A Boussiotis; D Neuberg; L L Brennan; N Hirano; L M Nadler; J G Gribben
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

5.  Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome.

Authors:  O Bestard; L Cuñetti; J M Cruzado; M Lucia; R Valdez; S Olek; E Melilli; J Torras; R Mast; M Gomà; M Franquesa; J M Grinyó
Journal:  Am J Transplant       Date:  2011-07-12       Impact factor: 8.086

Review 6.  Now or never? The case for cell-based immunosuppression in kidney transplantation.

Authors:  James A Hutchinson; Edward K Geissler
Journal:  Kidney Int       Date:  2015-03-04       Impact factor: 10.612

Review 7.  The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road.

Authors:  Lianjun Zhang; Yong Zhao
Journal:  J Cell Physiol       Date:  2007-06       Impact factor: 6.384

8.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

9.  Control of Foxp3 stability through modulation of TET activity.

Authors:  Xiaojing Yue; Sara Trifari; Tarmo Äijö; Ageliki Tsagaratou; William A Pastor; Jorge A Zepeda-Martínez; Chan-Wang J Lio; Xiang Li; Yun Huang; Pandurangan Vijayanand; Harri Lähdesmäki; Anjana Rao
Journal:  J Exp Med       Date:  2016-02-22       Impact factor: 14.307

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  4 in total

Review 1.  Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Authors:  Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal:  Cell Immunol       Date:  2020-07-15       Impact factor: 4.868

Review 2.  Advances in the immunology of heart transplantation.

Authors:  Joren C Madsen
Journal:  J Heart Lung Transplant       Date:  2017-10-20       Impact factor: 10.247

3.  RNA expression profiling of nonhuman primate renal allograft rejection identifies tolerance.

Authors:  R N Smith; M Matsunami; B A Adam; I A Rosales; T Oura; A B Cosimi; T Kawai; M Mengel; R B Colvin
Journal:  Am J Transplant       Date:  2018-02-17       Impact factor: 8.086

4.  Alloantigen-Induced Regulatory T Cells Generated in Presence of Vitamin C Display Enhanced Stability of Foxp3 Expression and Promote Skin Allograft Acceptance.

Authors:  Eirini Nikolouli; Matthias Hardtke-Wolenski; Martin Hapke; Michael Beckstette; Robert Geffers; Stefan Floess; Elmar Jaeckel; Jochen Huehn
Journal:  Front Immunol       Date:  2017-06-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.